{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:34:28Z","timestamp":1785270868223,"version":"3.55.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.semnephrol.2023.151471","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T14:15:04Z","timestamp":1704809704000},"page":"151471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["COVID and the Kidney: An Update"],"prefix":"10.1016","volume":"43","author":[{"given":"Samira","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffith B.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmila","family":"Anandh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2023.151471_bib0001","article-title":"Surveillance of SARS-CoV-2 at the Huanan Seafood Market","author":"Liu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0002","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19 - 17 August 2023. Accessed 26, September 2023. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19\u201417-august-2023"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151471_bib0003","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.kint.2020.06.002","article-title":"The forgotten fallen: painful reality of a pandemic","volume":"98","author":"Coates","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101317","article-title":"Variation in global COVID-19 symptoms by geography and by chronic disease: a global survey using the COVID-19 Symptom Mapper","volume":"45","author":"Kadirvelu","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151471_bib0005","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2666-5247(20)30223-8","article-title":"COVID-19 cytokine storm syndrome: a threshold concept","volume":"2","author":"Chen","year":"2021","journal-title":"Lancet Microbe"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151471_bib0006","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Starke","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0007","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1093\/cid\/ciaa1419","article-title":"Risk factors for coronavirus disease 2019 (COVID-19)\u2013associated hospitalization: COVID-19\u2013associated hospitalization surveillance network and behavioral risk factor surveillance system","volume":"72","author":"Ko","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151471_bib0008","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151471_bib0009","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0011","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"7847","key":"10.1016\/j.semnephrol.2023.151471_bib0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151471_bib0013","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151471_bib0014","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ckj\/sfaa160","article-title":"Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis","volume":"13","author":"Fu","year":"2020","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.xkme.2021.06.008","article-title":"Acute kidney injury in patients hospitalized with COVID-19 in New York City: temporal trends from March 2020 to April 2021","volume":"3","author":"Dellepiane","year":"2021","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2215\/CJN.09610620","article-title":"Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19","volume":"16","author":"Bowe","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151471_bib0017","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ekir.2021.01.036","article-title":"Decreasing incidence of acute kidney injury in patients with COVID-19 critical illness in New York City","volume":"6","author":"Charytan","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151471_bib0018","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ndt\/gfab303","article-title":"Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study","volume":"37","author":"Sullivan","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151471_bib0019","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1681\/ASN.2020050683","article-title":"Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19","volume":"31","author":"Golmai","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ajkd.2020.10.001","article-title":"Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria","volume":"77","author":"Akilesh","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151471_bib0021","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0022","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0023","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2170809","article-title":"Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis","volume":"45","author":"Zhang","year":"2023","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2020060897","article-title":"AKI treated with renal replacement therapy in critically ill patients with COVID-19","volume":"32","author":"Gupta","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101724","article-title":"Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study","volume":"55","author":"Tan","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0026","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ajkd.2021.11.004","article-title":"Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: the STOP-COVID cohort study","volume":"79","author":"Hsu","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0027","doi-asserted-by":"crossref","first-page":"m4677","DOI":"10.1136\/bmj.m4677","article-title":"Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study","volume":"371","author":"Xie","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0028","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","article-title":"Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis","volume":"78","author":"Chung","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151471_bib0029","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1681\/ASN.2020060875","article-title":"Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study","volume":"32","author":"De Meester","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"7821","key":"10.1016\/j.semnephrol.2023.151471_bib0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0031","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12882-020-02061-8","article-title":"COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry","volume":"21","author":"Bell","year":"2020","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151471_bib0032","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2022010046","article-title":"The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland","volume":"33","author":"Bell","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0033","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ckj\/sfac173","article-title":"The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland","volume":"16","author":"Bell","year":"2023","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250602","article-title":"Clinical determinants of the severity of COVID-19: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.kint.2022.05.015","article-title":"A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease","volume":"102","author":"Dashtban","year":"2022","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0036","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03168-2021","article-title":"Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study","volume":"60","author":"Lambourg","year":"2022","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151471_bib0037","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0038","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1038\/s41467-021-26602-3","article-title":"Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants","volume":"12","author":"Weigang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0039","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 variants in patients with immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0040","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2666-5247(22)00061-1","article-title":"Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations","volume":"3","author":"Li","year":"2022","journal-title":"Lancet Microbe"},{"issue":"7853","key":"10.1016\/j.semnephrol.2023.151471_bib0041","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0042","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12882-020-02061-8","article-title":"COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry","volume":"21","author":"Bell","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0043","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ekir.2020.12.013","article-title":"Systematic review and meta-analysis of COVID-19 and kidney transplant recipients, the South West London Kidney Transplant Network experience","volume":"6","author":"Phanish","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0044","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.35379","article-title":"COVID-19 risk factors and mortality outcomes among Medicare patients receiving long-term dialysis","volume":"4","author":"Salerno","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0045","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.kint.2020.09.006","article-title":"Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe","volume":"98","author":"Jager","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/TP.0000000000004059","article-title":"Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant recipients","volume":"106","author":"Callaghan","year":"2022","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151471_bib0047","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2022010046","article-title":"The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland","volume":"33","author":"Bell","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0048","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1016\/S2665-9913(22)00216-8","article-title":"COVID-19 vaccine effectiveness against omicron (B. 1.1. 529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study","volume":"4","author":"Risk","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0049","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.kint.2022.02.015","article-title":"Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19","volume":"101","author":"Perkins","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0050","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety","volume":"14","author":"Mascellino","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0051","series-title":"How Do the New COVID-19 Vaccines Work?","author":"Goldman","year":"2020"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151471_bib0052","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.ki.5002425","article-title":"Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients","volume":"72","author":"Lim","year":"2007","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0053","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41590-023-01508-y","article-title":"Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities","volume":"24","author":"Zhang","year":"2023","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151471_bib0054","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJMc2216309","article-title":"Immunologic effect of bivalent mRNA booster in patients undergoing hemodialysis","volume":"388","author":"Huth","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151471_bib0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.ekir.2023.04.026","article-title":"Humoral and T cell responses to SARS-CoV-2 vaccine booster and anti-SARS-CoV-2 monoclonal antibodies in patients with end-stage kidney disease","volume":"8","author":"Zaza","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"25","key":"10.1016\/j.semnephrol.2023.151471_bib0056","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and kidney transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151471_bib0057","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0000000000004200","article-title":"Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge","volume":"106","author":"Avery","year":"2022","journal-title":"Transplantation"},{"issue":"10310","key":"10.1016\/j.semnephrol.2023.151471_bib0058","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(21)02096-1","article-title":"Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients","volume":"398","author":"Prendecki","year":"2021","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.semnephrol.2023.151471_bib0059","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151471_bib0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.kint.2022.01.017","article-title":"A fourth SARS-Cov-2 mRNA vaccine in strictly seronegative kidney transplant recipients","volume":"101","author":"Masset","year":"2022","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0061","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/L21-0598","article-title":"Antibody response to a fourth messenger RNA COVID-19 vaccine dose in kidney transplant recipients: a case series","volume":"175","author":"Caillard","year":"2022","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151471_bib0062","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1097\/TP.0000000000003934","article-title":"Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series","volume":"105","author":"Alejo","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101642","article-title":"Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients","volume":"53","author":"Thomson","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0064","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-023-00824-8","article-title":"Humoral and cellular immunity to SARS-CoV-2 ancestral and Omicron BA. 5 variants following vaccination in myelofibrosis patients","volume":"13","author":"Alcheikh","year":"2023","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0066","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.42058","article-title":"Rituximab impairs B cell response but not T cell response to COVID-19 vaccine in autoimmune diseases","volume":"74","author":"Bitoun","year":"2022","journal-title":"Arthritis Rheum"},{"issue":"636","key":"10.1016\/j.semnephrol.2023.151471_bib0067","doi-asserted-by":"crossref","first-page":"eabl6141","DOI":"10.1126\/scitranslmed.abl6141","article-title":"Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients","volume":"14","author":"Charmetant","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0068","article-title":"Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid","volume":"9","author":"Benning","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151471_bib0069","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157836","article-title":"Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination\u2013specific humoral and cellular immunity in kidney transplant recipients","volume":"7","author":"Schrezenmeier","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151471_bib0070","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/TP.0000000000004177","article-title":"Enhanced humoral immune response after COVID-19 vaccination in elderly kidney transplant recipients on everolimus versus mycophenolate mofetil\u2013containing immunosuppressive regimens","volume":"106","author":"de Boer","year":"2022","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0071","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(22)00650-8","article-title":"Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial","volume":"23","author":"Kho","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151471_bib0072","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0073","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2019.04.020","article-title":"ATHENA: wisdom and warfare in defining the role of de novo mTOR inhibition in kidney transplantation","volume":"96","author":"Chadban","year":"2019","journal-title":"Kidney Int"},{"issue":"25","key":"10.1016\/j.semnephrol.2023.151471_bib0074","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-6143.2010.03407.x","article-title":"Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques","volume":"11","author":"Turner","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0076","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0105-2896.2010.00898.x","article-title":"The role of mTOR in memory CD8+ T-cell differentiation","volume":"235","author":"Araki","year":"2010","journal-title":"Immunol Rev"},{"issue":"7251","key":"10.1016\/j.semnephrol.2023.151471_bib0077","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"issue":"449","key":"10.1016\/j.semnephrol.2023.151471_bib0078","doi-asserted-by":"crossref","first-page":"eaaq1564","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci Transl Med"},{"issue":"268","key":"10.1016\/j.semnephrol.2023.151471_bib0079","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0080","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2666-7568(21)00062-3","article-title":"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials","volume":"2","author":"Mannick","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0081","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/ajt.16958","article-title":"mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients","volume":"22","author":"Netti","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0082","first-page":"2023","article-title":"mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients","author":"Perkins","year":"2023","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151471_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-022-06634-w","article-title":"Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)\u2014rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients","volume":"23","author":"Tunbridge","year":"2022","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151471_bib0084","doi-asserted-by":"crossref","first-page":"e14016","DOI":"10.1111\/tid.14016","article-title":"SARS-CoV-2 seropositivity in renal transplant patients administered intravenous immunoglobulin","volume":"25","author":"Sim","year":"2023","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151471_bib0085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2204919","article-title":"Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge","volume":"387","author":"Arbel","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151471_bib0086","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/1120009X.2022.2099693","article-title":"Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story","volume":"34","author":"Panagopoulos","year":"2022","journal-title":"J Chemother"},{"issue":"23","key":"10.1016\/j.semnephrol.2023.151471_bib0087","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (tixagevimab\u2013cilgavimab) for prevention of COVID-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151471_bib0088","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.kint.2022.07.022","article-title":"A rapid decline in the anti\u2013receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab\u2013cilgavimab administration","volume":"102","author":"Benotmane","year":"2022","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151471_bib0089","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/ajt.17128","article-title":"Tixagevimab\/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave","volume":"22","author":"Al Jurdi","year":"2022","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151471_bib0090","doi-asserted-by":"crossref","first-page":"1654.e1","DOI":"10.1016\/j.cmi.2022.07.015","article-title":"Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients","volume":"28","author":"Nguyen","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0091","article-title":"Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform","volume":"379","author":"Zheng","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0092","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/ckj\/sfad184","article-title":"Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database","volume":"16","author":"Collaborative","year":"2023","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0093","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0094","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1681\/ASN.2021060734","article-title":"Kidney outcomes in long COVID","volume":"32","author":"Bowe","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"10270","key":"10.1016\/j.semnephrol.2023.151471_bib0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2023.151471_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103817","article-title":"Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: a cohort study","volume":"76","author":"Gu","year":"2022","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151471_bib0097","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehab914","article-title":"Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme","volume":"43","author":"Petersen","year":"2022","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151471_bib0098","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062747","volume":"12","author":"Singer","year":"2022","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151471_bib0099","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/vaccines10101685","article-title":"Benefits of switching mycophenolic acid to sirolimus on serological response after a SARS-CoV-2 booster dose among kidney transplant recipients: a pilot study","volume":"10","author":"Banjongjit","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151471_bib0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ekir.2022.04.002","article-title":"COVID-19 vaccination response in kidney transplant recipients with and without mycophenolate mofetil: follow-up of a randomized controlled trial","volume":"7","author":"Al Fatly","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151471_bib0101","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055611","article-title":"Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)","volume":"11","author":"Yahav","year":"2021","journal-title":"BMJ Open"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952300181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952300181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T22:22:09Z","timestamp":1748384529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092952300181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S027092952300181X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151471","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID and the Kidney: An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151471"}}